SUN PHARMACEUTICAL INDUSTRIES
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr |
| Equity - Authorised | ₹617 Cr | ₹599 Cr | ₹599 Cr | ₹599 Cr | ₹599 Cr |
| Equity - Issued | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr |
| Equity Paid Up | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹83,330 Cr | ₹71,978 Cr | ₹63,427 Cr | ₹55,755 Cr | ₹47,771 Cr |
| Securities Premium | ₹1,187 Cr | ₹1,187 Cr | ₹1,187 Cr | ₹1,187 Cr | ₹1,187 Cr |
| Capital Reserves | ₹368 Cr | ₹368 Cr | ₹368 Cr | ₹368 Cr | ₹368 Cr |
| Profit & Loss Account Balance | ₹69,355 Cr | ₹57,862 Cr | ₹50,155 Cr | ₹43,610 Cr | ₹37,646 Cr |
| General Reserves | ₹84 Cr | ₹3,562 Cr | ₹3,562 Cr | ₹3,562 Cr | ₹3,562 Cr |
| Other Reserves | ₹12,336 Cr | ₹8,999 Cr | ₹8,155 Cr | ₹7,028 Cr | ₹5,008 Cr |
| Reserve excluding Revaluation Reserve | ₹83,330 Cr | ₹71,978 Cr | ₹63,427 Cr | ₹55,755 Cr | ₹47,771 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹83,570 Cr | ₹72,218 Cr | ₹63,667 Cr | ₹55,995 Cr | ₹48,011 Cr |
| Minority Interest | ₹310 Cr | ₹268 Cr | ₹3,459 Cr | ₹3,320 Cr | ₹3,055 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | ₹31 Cr | ₹2.52 Cr | ₹1.33 Cr | - | ₹230 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | ₹31 Cr | - | - | - | ₹230 Cr |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | ₹2.52 Cr | ₹1.33 Cr | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-3,668 Cr | ₹-4,215 Cr | ₹-3,932 Cr | ₹-3,487 Cr | ₹-2,818 Cr |
| Deferred Tax Assets | ₹5,745 Cr | ₹6,507 Cr | ₹6,515 Cr | ₹5,695 Cr | ₹4,431 Cr |
| Deferred Tax Liability | ₹2,077 Cr | ₹2,292 Cr | ₹2,584 Cr | ₹2,208 Cr | ₹1,613 Cr |
| Other Long Term Liabilities | ₹1,349 Cr | ₹752 Cr | ₹802 Cr | ₹1,147 Cr | ₹902 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹525 Cr | ₹474 Cr | ₹414 Cr | ₹343 Cr | ₹369 Cr |
| Total Non-Current Liabilities | ₹-1,763 Cr | ₹-2,987 Cr | ₹-2,714 Cr | ₹-1,998 Cr | ₹-1,316 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹7,334 Cr | ₹6,184 Cr | ₹5,653 Cr | ₹5,682 Cr | ₹4,490 Cr |
| Sundry Creditors | ₹7,334 Cr | ₹6,184 Cr | ₹5,653 Cr | ₹5,682 Cr | ₹4,490 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹3,944 Cr | ₹3,254 Cr | ₹2,717 Cr | ₹2,604 Cr | ₹2,927 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹137 Cr | ₹25 Cr | ₹43 Cr | ₹41 Cr | ₹29 Cr |
| Interest Accrued But Not Due | ₹2.77 Cr | ₹4.37 Cr | ₹6.94 Cr | ₹22 Cr | ₹2.90 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹3,804 Cr | ₹3,225 Cr | ₹2,667 Cr | ₹2,541 Cr | ₹2,895 Cr |
| Short Term Borrowings | ₹4,050 Cr | ₹1,867 Cr | ₹2,844 Cr | ₹5,958 Cr | ₹469 Cr |
| Secured ST Loans repayable on Demands | - | - | - | - | - |
| Working Capital Loans- Sec | - | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹4,050 Cr | ₹1,867 Cr | ₹2,844 Cr | ₹5,958 Cr | ₹469 Cr |
| Short Term Provisions | ₹7,294 Cr | ₹6,888 Cr | ₹5,769 Cr | ₹5,663 Cr | ₹9,323 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹1,350 Cr | ₹733 Cr | ₹412 Cr | ₹309 Cr | ₹176 Cr |
| Provision for post retirement benefits | - | - | - | - | ₹427 Cr |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹5,944 Cr | ₹6,155 Cr | ₹5,358 Cr | ₹5,354 Cr | ₹8,720 Cr |
| Total Current Liabilities | ₹22,622 Cr | ₹18,194 Cr | ₹16,984 Cr | ₹19,906 Cr | ₹17,208 Cr |
| Total Liabilities | ₹104,739 Cr | ₹87,693 Cr | ₹81,396 Cr | ₹77,225 Cr | ₹66,958 Cr |
| ASSETS | |||||
| Gross Block | ₹60,321 Cr | ₹45,950 Cr | ₹44,320 Cr | ₹43,100 Cr | ₹38,707 Cr |
| Less: Accumulated Depreciation | ₹27,499 Cr | ₹23,363 Cr | ₹21,072 Cr | ₹19,035 Cr | ₹16,042 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹32,822 Cr | ₹22,586 Cr | ₹23,248 Cr | ₹24,065 Cr | ₹22,665 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹1,381 Cr | ₹1,234 Cr | ₹1,108 Cr | ₹963 Cr | ₹798 Cr |
| Non Current Investments | ₹3,789 Cr | ₹4,698 Cr | ₹6,441 Cr | ₹5,452 Cr | ₹5,215 Cr |
| Long Term Investment | ₹3,789 Cr | ₹4,698 Cr | ₹6,441 Cr | ₹5,452 Cr | ₹5,215 Cr |
| Quoted | ₹2,992 Cr | ₹4,149 Cr | ₹5,677 Cr | ₹4,487 Cr | ₹4,243 Cr |
| Unquoted | ₹1,244 Cr | ₹956 Cr | ₹879 Cr | ₹1,079 Cr | ₹1,085 Cr |
| Long Term Loans & Advances | ₹1,133 Cr | ₹1,016 Cr | ₹2,785 Cr | ₹2,758 Cr | ₹2,881 Cr |
| Other Non Current Assets | ₹52 Cr | ₹124 Cr | ₹93 Cr | ₹93 Cr | ₹46 Cr |
| Total Non-Current Assets | ₹40,848 Cr | ₹35,069 Cr | ₹37,921 Cr | ₹37,341 Cr | ₹32,094 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹20,933 Cr | ₹13,656 Cr | ₹8,585 Cr | ₹9,373 Cr | ₹7,634 Cr |
| Quoted | ₹1,647 Cr | ₹2,916 Cr | ₹4,199 Cr | ₹4,935 Cr | ₹4,032 Cr |
| Unquoted | ₹19,287 Cr | ₹10,740 Cr | ₹4,386 Cr | ₹4,438 Cr | ₹3,602 Cr |
| Inventories | ₹11,493 Cr | ₹10,243 Cr | ₹9,868 Cr | ₹10,513 Cr | ₹8,925 Cr |
| Raw Materials | ₹4,179 Cr | ₹3,436 Cr | ₹3,130 Cr | ₹3,478 Cr | ₹2,914 Cr |
| Work-in Progress | ₹1,913 Cr | ₹2,019 Cr | ₹2,010 Cr | ₹2,497 Cr | ₹2,058 Cr |
| Finished Goods | ₹4,134 Cr | ₹3,709 Cr | ₹3,735 Cr | ₹3,451 Cr | ₹3,065 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | ₹209 Cr | ₹214 Cr | ₹148 Cr | ₹131 Cr | ₹122 Cr |
| Other Inventory | ₹1,059 Cr | ₹864 Cr | ₹846 Cr | ₹955 Cr | ₹767 Cr |
| Sundry Debtors | ₹15,510 Cr | ₹13,046 Cr | ₹11,249 Cr | ₹11,439 Cr | ₹10,485 Cr |
| Debtors more than Six months | ₹478 Cr | ₹458 Cr | ₹657 Cr | ₹561 Cr | ₹469 Cr |
| Debtors Others | ₹15,324 Cr | ₹12,915 Cr | ₹10,999 Cr | ₹11,293 Cr | ₹10,492 Cr |
| Cash and Bank | ₹11,603 Cr | ₹11,332 Cr | ₹10,521 Cr | ₹5,770 Cr | ₹5,033 Cr |
| Cash in hand | ₹1.77 Cr | ₹1.59 Cr | ₹1.80 Cr | ₹2.14 Cr | ₹1.52 Cr |
| Balances at Bank | ₹11,559 Cr | ₹11,259 Cr | ₹10,496 Cr | ₹5,759 Cr | ₹5,018 Cr |
| Other cash and bank balances | ₹42 Cr | ₹71 Cr | ₹22 Cr | ₹9.49 Cr | ₹14 Cr |
| Other Current Assets | ₹715 Cr | ₹625 Cr | ₹756 Cr | ₹746 Cr | ₹775 Cr |
| Interest accrued on Investments | ₹53 Cr | ₹62 Cr | ₹43 Cr | ₹33 Cr | ₹10 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹459 Cr | ₹375 Cr | ₹414 Cr | ₹372 Cr | ₹286 Cr |
| Other current_assets | ₹204 Cr | ₹188 Cr | ₹300 Cr | ₹342 Cr | ₹478 Cr |
| Short Term Loans and Advances | ₹3,606 Cr | ₹3,692 Cr | ₹2,454 Cr | ₹2,022 Cr | ₹2,013 Cr |
| Advances recoverable in cash or in kind | ₹649 Cr | ₹616 Cr | ₹515 Cr | ₹545 Cr | ₹405 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹2,957 Cr | ₹3,076 Cr | ₹1,939 Cr | ₹1,476 Cr | ₹1,607 Cr |
| Total Current Assets | ₹63,860 Cr | ₹52,594 Cr | ₹43,433 Cr | ₹39,862 Cr | ₹34,865 Cr |
| Net Current Assets (Including Current Investments) | ₹41,238 Cr | ₹34,400 Cr | ₹26,449 Cr | ₹19,956 Cr | ₹17,656 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹104,739 Cr | ₹87,693 Cr | ₹81,396 Cr | ₹77,225 Cr | ₹66,958 Cr |
| Contingent Liabilities | ₹1,587 Cr | ₹4,276 Cr | ₹4,567 Cr | ₹4,061 Cr | ₹3,647 Cr |
| Total Debt | ₹4,082 Cr | ₹1,870 Cr | ₹2,846 Cr | ₹6,198 Cr | ₹931 Cr |
| Book Value | 348.31 | 301.00 | 265.36 | 233.38 | 200.11 |
| Adjusted Book Value | 348.31 | 301.00 | 265.36 | 233.38 | 200.11 |
Compare Balance Sheet of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,188.3 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
| MANKIND PHARMA | ₹104,544.0 Cr | 0% | 5.9% | 4.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 1.8% |
9% |
12.5% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses